Smad1 has been identified as a target of miR-26b-5p in hepatocellular carcinoma metastases and during EMT [59], supporting its involvement in EMT-driven metastatic progression across multiple cancer types. The gene discussed is SMAD1; the disease is hepatocellular carcinoma.